BioNTech and Pfizer investigate new vaccine candidate: should also be effective against omikron

German pharmaceutical company BioNTech and its American partner Pfizer have launched a new study into the efficacy and safety of a vaccine candidate. The possible vaccine would work according to the same mRNA technology as the existing corona vaccine from BioNTech and Pfizer. The pharmaceutical companies reported this on Wednesday.

ttn-3